Another study in patients with obesity and T2D showed that fluctuation in a ghrelin gene product (unacylated ghrelin) after RYGB was associated with the reduction in BMD [59]. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.